BioSpecifics Technologies Corp.
BSTC
BSTC was delisted on the 1st of December, 2020.
96 hedge funds and large institutions have $223M invested in BioSpecifics Technologies Corp. in 2016 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 34 increasing their positions, 37 reducing their positions, and 9 closing their positions.
78% more first-time investments, than exits
New positions opened: 16 | Existing positions closed: 9
28% more capital invested
Capital invested by funds: $175M → $223M (+$48.2M)
7% more funds holding
Funds holding: 90 → 96 (+6)
8% less repeat investments, than reductions
Existing positions increased: 34 | Existing positions reduced: 37
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NI
Numeric Investors
Boston,
Massachusetts
|
+$7.41M |
| 2 |
Renaissance Technologies
New York
|
+$1.48M |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
+$1.45M |
| 4 |
MCM
Matarin Capital Management
New York
|
+$1.45M |
| 5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$1.23M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCMC
RK Capital Management (Colorado)
Denver,
Colorado
|
-$3.74M |
| 2 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
-$1.81M |
| 3 |
RA
Royce & Associates
New York
|
-$1.47M |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
-$877K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$846K |
BSTC Hedge Fund Activity: Q4 2016 in Review
96 of the 4,008 institutional investors tracked by Wall St. Rank reported a position in BioSpecifics Technologies Corp. (BSTC) for Q4 2016, worth a combined $223M — up 28% from $175M a quarter earlier.
Buyers outnumbered sellers: 16 funds opened new BSTC positions and 9 closed out — a net gain of 7 holders — while 34 added to existing stakes and 37 trimmed.
The largest buyer was Numeric Investors, opening a new position worth an estimated $7.41M. The largest seller was RK Capital Management (Colorado), cutting an estimated $3.74M.
- 96 institutional investors held BioSpecifics Technologies Corp. (BSTC) as of Q4 2016, up from 90 in Q3 2016.
- Funds reported $223M of BioSpecifics Technologies Corp. stock for Q4 2016, up 28% quarter-over-quarter.
- 16 funds opened new BioSpecifics Technologies Corp. positions in Q4 2016 and 9 closed out, a net change of +7 holders.
- The largest BioSpecifics Technologies Corp. buyer in Q4 2016 was Numeric Investors, an estimated $7.41M added.
- The largest BioSpecifics Technologies Corp. seller in Q4 2016 was RK Capital Management (Colorado), an estimated $3.74M sold.
Based on aggregated 13F filings for Q4 2016.